Skip to main content
Anurag Mehta, MD, Cardiology, Reno, NV

AnuragMehtaMDF.A.C.C

Cardiology Reno, NV

Interventional Cardiology

Chief of Staff, Veteran Medical systems of the Ozark, Fayetteville, AR

Dr. Mehta is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Mehta's full profile

Already have an account?

  • Office

    1500 E 2nd St
    Ste 302
    Reno, NV 89502
    Phone+1 775-784-1223

Education & Training

  • West Virginia University
    West Virginia UniversityFellowship, Cardiovascular Disease, 1995 - 1998
  • West Virginia University
    West Virginia UniversityResidency, Internal Medicine, 1992 - 1995
  • New York Medical College (Brooklyn-Queens)
    New York Medical College (Brooklyn-Queens)Internship, Internal Medicine, 1991 - 1992
  • J.J.M. Medical College
    J.J.M. Medical CollegeClass of 1987

Certifications & Licensure

  • NV State Medical License
    NV State Medical License 2007 - 2025
  • LA State Medical License
    LA State Medical License 2004 - 2020
  • MS State Medical License
    MS State Medical License 2001 - 2020
  • WV State Medical License
    WV State Medical License 1996 - 2003

Awards, Honors, & Recognition

  • Fellow (FACC) American College of Cardiology

Publications & Presentations

PubMed

Abstracts/Posters

  • [Board 394] Sex-Differences in Circulating Soluble Urokinase-Type Plasminogen Activator Receptor (suPAR) Levels and Its Impact on the Prognostic Significance of suPAR ...
    Anurag Mehta, 2019 ACC Scientific Session & Expo, New Orleans, New Orleans, 3/17/2019

Lectures

  • Audience ARS Question: Top 3 Presentations in Diabetes/Cardiometabolic Disorders Most Likely to Impact or Change Clinical Practice or Future Research Agenda 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
  • My ASCVD Patient's LDL-C is 80 mg/dL. Should I Use A PCSK9 Inhibitor? 
    2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019

Authored Content

  • Older Adults and Hypertension: Beyond the 2017 Guideline for Prevention, Detection, Evaluation, and Management of High Blood Pressure in AdultsFebruary 2020

Professional Memberships